Parnax Lab Limited (BSE: 506128)
Health Care · Pharmaceuticals · IN
Rs117.00
+1.74% today · -8.8% 1Y
Parnax Lab Limited (BSE: 506128) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.89M.
Over the last twelve months the share price has lost 8.8%, trading between 99.20 and 182.00.
Tweenvest scores Parnax Lab Limited across four factors: quality 59/100, value 49/100, growth 46/100. Its strongest factor is quality.
506128 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.89M
- Revenue (TTM)
- $26.65M
- P/E
- 15.03
- EPS
- 7.78
- Dividend yield
- —
- Beta (5Y)
- 0.05
- 52-week high
- Rs182.00
- 52-week low
- Rs99.20
- Avg volume (3M)
- —
- Shares outstanding
- 11.49M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lobe Sciences Ltd.CNSX: LOBE | $14.28M | CA$0.06 | +9.09% |
| Lipocine Inc.NasdaqCM: LPCN | $14.18M | $1.72 | -16.10% |
| Panchsheel Organics LimitedBSE: 531726 | $14.04M | Rs103.15 | +0.29% |
| Pharma Equity Group A/SCPSE: PEG | $14.01M | Dkr0.08 | -2.06% |
| Biotika a.s.BSSE: 1BSL01AE | $13.81M | €— | — |
| Yi Po International Holding LimitedOTCPK: YBZN | $13.77M | $— | — |
| Tvardi Therapeutics, Inc.NasdaqCM: TVRD | $13.74M | $1.03 | -10.43% |
| WooGene B&G Co., LtdKOSDAQ: A018620 | $13.72M | ₩2,660.00 | -0.19% |
Figures last refreshed Oct 11, 2026.